Evolving disease characteristics in cardiac amyloidosis: real-world data from a tertiary referral center

17 May 2025 (11:00 - 11:45)

Organised by:

Video

Abstract

Slides

Sign in for access options

About the speaker

Doctor Peter-Paul Zwetsloot

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail

Comparison of inferior vena cava wall thickness in patients with cardiac amyloidosis versus hypertrophic cardiomyopathy, a new diagnostic tool

Doctor T. Li (Singapore, SG)

Abstract Slides Video

Presentation thumbnail

Automated detection of amyloid birefringence by digital pathology in endomyocardial biopsies

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Simple and specific prediction of the final diagnosis in patients with suspected amyloid cardiomyopathy and indication to tissue biopsy

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy

Doctor R. Saro (Fuerth, DE) Doctor M. Merlo (Trieste, IT)

Abstract Slides Video

Presentation thumbnail

Hemodynamic gain index in cardiac amyloidosis

Doctor E. Fiori (Rome, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Phenotyping of amyloidosis

The Event

Event poster

Heart Failure 2025

17 May 2025 11:00 CET

You may be interested in

Congress Presentation

Outcomes with early access tafamidis in patients with variant transthyretin amyloid cardiomyopathy

Congress Presentation

Temporal trends and outcomes of heart failure patients between light-chain cardiac amyloidosis and transthyretin cardiac amyloidosis: insights from the national inpatient sample database

Congress Session

Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources